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Summary
We describe two familial cases of dominant dystrophic
epidermolysis bullosa (DDEB) that are heterozygous for
deletions in COL7A1 that alter splicing, despite intact
consensus splice-site sequences. One patient shows a 28-
bp genomic deletion (6081del28) in exon 73 associated
with the activation of a cryptic donor splice site within
this exon; the combination of both defects restores the
phase and replaces the last 11 Gly-X-Y repeats of exon
73 by a noncollagenous sequence, Glu-Ser-Leu. The sec-
ond patient demonstrates a 27-bp deletion in exon 87
(6847del27), causing in-frame skipping of this exon;
consensus splice sites, putative branch sites, and introns
flanking exons 73 and 87 showed a normal sequence.
Keratinocytes from the probands synthesized normal
and shortened type VII collagen polypeptides and
showed intracellular accumulation of type VII procol-
lagen molecules. This first report of genomic deletions
in COL7A1 in DDEB suggests a role for exonic se-
quences in the control of splicing of COL7A1 pre-
mRNA and provides evidence that shortened type VII
collagen polypeptides can alter, in a dominant manner,
anchoring-fibril formation and can cause DDEB of dif-
fering severity.
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Introduction
Epidermolysis bullosa (EB) comprises a heterogeneous
group of hereditary skin diseases characterized by blis-
tering of the skin and mucous membranes after mild
trauma (Fine et al. 1991; Bruckner-Tuderman 1993).
The dystrophic forms of EB (DEB) demonstrate cleavage
beneath the lamina densa, at the level of anchoring fibrils
(AFs), which show various abnormalities (Tidman and
Eady 1985; McGrath et al. 1993). DEB occurs in both
a dominantly inherited form (DDEB) and a recessively
inherited form (RDEB), each form being subdivided into
different clinical subtypes. Close linkage has been estab-
lished between the type VII collagen gene (COL7A1) on
chromosomal region 3p21, which encodes the consti-
tutive molecules of AFs (Burgeson et al. 1990), and both
DDEB and RDEB (Ryyna¨nen et al. 1991; Al-Imara et
al. 1992; Hovnanian et al. 1992; Dunnill et al. 1994;
Naeyaert et al. 1995). Distinct COL7A1 mutations have
been identified in DDEB and RDEB, which allow for
some genotype-phenotype correlations to emerge (re-
viewed in Ja¨rvikallio et al. 1997).
DDEB comprises two major forms, the Cockayne-
Touraine variant and the Pasini variant, which display
generalized blistering, predominantly at sites of trauma.
The other subtypes of DDEB include the pretibial form,
which is a rare and localized clinical variant; the pru-
riginosa type, which is associated with severe pruritus,
prurigo nodules, and scarring of the extensors of the
extremities; and Bart syndrome, which presents with
congenital absence of skin on the lower extremities (Fine
et al. 1991). Blistering of the skin leads to scarring and
milia, sometimes associated with albopapuloid lesions;
nails are frequently dystrophic; and oral blistering can
occur. Electron-microscopic studies show AF abnor-
malities, which can be reduced in number and rudimen-
tary in appearance. Immunofluorescence staining using
LH7:2 antibody against type VII collagen is sometimes
reduced but is often normal (McGrath et al. 1993).
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Dominant transient bullous dermolysis of the newborn
is a particular form of the disease, with neonatal blis-
tering that heals within the first months or 1st year of
life and is associated with transient intracellular reten-
tion of type VII collagen (Fine et al. 1991). COL7A1
mutations have been identified in all known DDEB
forms, indicating that DDEB subtypes are allelic variants
caused by different mutations in the same gene (Chris-
tiano et al. 1994c, 1995a, 1995b, 1996a, 1996b, 1996c;
Kon et al. 1997a, 1997b; Lee et al. 1997). Apart from
a splice-site mutation identified in a family with domi-
nantly inherited transient bullous dermolysis of the new-
born (Christiano et al. 1997b), COL7A1 mutations de-
scribed so far in DDEB all involve glycine substitutions
within the triple-helical domain of the molecule. By anal-
ogy with glycine substitutions identified in other collagen
genes in inherited connective-tissue disorders reviewed
by Byers (1990) and Kuivaniemi et al. (1991), substi-
tutions of these glycine residues in COL7A1 are thought
to have a dominant-negative effect on both type VII
collagen assembly and AF formation. In contrast, a ma-
jority of mutations in RDEB result in premature-ter-
mination codons (PTCs), leading to mRNA instability
and absence of type VII collagen protein synthesis (Hilal
et al. 1993; Christiano et al. 1994a, 1995c, 1997a;Hov-
nanian et al. 1994, 1997; Dunnill et al. 1996; Ham-
mami-Hauasli et al. 1997). However, glycine substitu-
tions in the collagenous domain of type VII collagen also
have been reported in RDEB, indicating that some gly-
cine substitutions act in a recessive manner (Christiano
et al. 1996c; Hovnanian et al. 1997; Kon et al. 1997a).
Collagen VII molecules are homotrimers made of
proa1(VII) chains. Each chain consists of a large (145
kD) central triple-helical collagenous domain flanked by
an amino-terminal (145 kD) and a carboxy-terminal (30
kD) noncollagenous domain (Burgeson 1993). The cen-
tral domain contains a repeating Gly-X-Y collagenous
sequence, which folds into triple-helical conformation.
The Gly-X-Y motif is interrupted 19 times by noncol-
lagenous regions that are thought to provide flexibility
to the molecule. AFs are formed by antiparallel associ-
ation of homotrimers, through their NC-2 domains and
by lateral aggregation of the collagenous domains of the
molecules. They provide critical cohesion of the epider-
mis to the dermis, via interactions both with components
of the lamina densa and with anchoring plaques in the
dermis (Burgeson et al. 1990).
A growing body of evidence indicates that exons con-
tain sequences that assist in exon definition during splic-
ing in vertebrate genes (Reed and Maniatis 1986). The
role of such sequences in splice-site selection was de-
scribed initially in genes undergoing differential splicing
and now has been documented in several human disease
genes (Cooper and Mattox 1997). These observations
have supported the “exon definition” model whereby
splice-site recognition requires pairing between 5′ and 3′
splice sites across the exon, via binding of small nuclear
ribonucleoproteins and associated specific transacting
factors that form the spliceosome (Berget 1995). Among
the exonic sequences involved in splice-site selection are
“exonic splicing enhancers” (ESEs), which often are pu-
rine-rich sequences that bind serine and arginine-rich
(SR) proteins during spliceosome assembly. ESE se-
quences also include AC-rich enhancers (ACEs) and
other sequences that do not resemble purine-rich ESEs
or ACEs (Coulter et al. 1997). In support of the role of
exons in splicing, point mutations in ESEs sequences that
cause skipping of the exon harboring the mutation re-
cently have been reported in human disease genes (re-
viewed in Cooper and Mattox 1997). Large deletions
or insertions within exons also have been shown to affect
splicing and to cause exon skipping, suggesting that the
size and/or secondary structure of the exon also are crit-
ical for exon recognition (Reed andManiatis 1986;Mat-
suo et al. 1992).
Here we have studied two familial cases of DDEB in
which the disease severity showed marked improvement
with age, and we have identified genomic deletions in
exons 73 and 87 of COL7A1. Although these defects
are located some distance from the consensus splice sites,
splicing of the corresponding exon is altered and causes
in-frame skipping of collagenous sequences. As a con-
sequence, shortened proa1(VII) chains are produced,
and keratinocytes in culture show intracellular accu-
mulation of type VII collagen polypeptide. These data
reveal that the integrity of exons 73 and 87 is essential
for normal splicing of COL7A1 pre-mRNA and indicate
that shortened proa1(VII) chains can impair, in a dom-
inant manner, AF formation.
Subjects and Methods
Clinical Features of Subjects
Family 1.—The proband is a 32-year-old White South
African woman. She is the third child of unrelated and
unaffected parents. She was noted at birth to have hem-
orrhagic blisters underneath both thumbnails and to
have dystrophic nails. During childhood, she had
trauma-induced blisters on her knees, elbows, ankles,
and the dorsum of her feet. She also presented with
hemorrhagic blisters in her mouth. Blistering was at its
most severe during early childhood and diminished
markedly at the onset of adulthood. On examination at
age of 32 years, she had minimal milia and scarring but
had markedly dystrophic fingernails and toenails (fig.
1a). The patient recently gave birth to her first child, an
affected daughter who displayed congenital absence of
skin of the right leg and foot (fig. 1b). The skin condition
of her daughter improved after birth, but blistering still
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Figure 1 Clinical presentation of patients and of patient 1’s
daughter. a, Patient 1 at age 32 years, showing dystrophic finger nails
with minimal scarring. b, Patient 1’s daughter, showing congenital
absence of skin of the posterior aspect of the right leg and heel. c,
Patient 2 at age 10 years, showing blistering and atrophic scarring on
the pretibial area and knees, with numerous and hypertrophic milia.
occurs after relatively mild trauma. The condition of the
patient and her daughter was consistent with DDEB.
Family 2.—The proband is a 10-year-old French girl
who is the only child of unrelated parents. She developed
trauma-induced erosions and blisters mainly on pretibial
area and knees after the age of 7 mo. Some blisters and
milia also developed on fingers. On examination, she
had red atrophic scars on the knees, on pretibial areas,
and on the ankles, with numerous and hypertrophic
milia (fig. 1c). Pruritus was frequent. Her toenails were
dystrophic; her mucous membranes were not affected.
No albopapuloid lesions were observed. Her father and
paternal grandmother had had dystrophic nails since
childhood. They had developed blistering to a lesser ex-
tent than had the proband. In particular, blistering in
her father and grandmother spared pretibial skin and
had improved markedly by the onset of adulthood. Clin-
ical examination of her father, at age of 45 years, showed
nail dystrophy with neither atrophic scars normilia. This
family presented with the diagnosis of pretibial DDEB
with intrafamilial variability.
PCR Amplification
After informed consent was obtained, DNA was iso-
lated from peripheral blood leukocytes and was used as
a template for amplification of genomic sequenceswithin
COL7A1. Oligonucleotide primers were designed to
generate 62 PCR products spanning all 118 exons and
flanking splice sites of COL7A1 (Christiano et al.
1997c). PCR amplification was performed by use of 100
ng genomic DNA as a template in 50 ml of reaction
mixture that contained 200 mM of each dNTP, 12.5 pM
of each primer, 1.5 mM magnesium chloride, 45 mM
Tris pH 8.8, 11 mM ammonium sulfate, and 6.7 mM
b-mercaptoethanol with 0.4 U AmpliTaq polymerase
(Perkin Elmer). The following conditions were used: hot
start, 35 cycles of 94C for 30 s, Tm of the primers for
40 s, and 72C for 30 s, in a MJ Research PTC-100
thermal cycler. The primer sets used to detect the mu-
tations from genomic DNA were as follows: for exon
73, sense primer 5′-GGGTGTAGCTGTACAGCCAC-3′
and the anti-sense primer 5′-CCCTCTTCCCTCACT-
CTCCT-3′ (nucleotide positions 23399–23684 in the ge-
nomic sequence [Genbank accession number L23982]);
for exon 87, sense primer 5′-GTCAAGGGTTGGGCT-
CCAGG-3′ and antisense primer 5′-TGGAAACAGGCT-
TGTGGGTG-3′ (nucleotide positions 25974–26377).
The annealing temperatures used were 55C and 60C
for exons 73 and 87, respectively.
The mutations were investigated by amplification of
reverse-transcribed RNA from keratinocytes by use of
COL7A1 cDNA primers encompassing the exons flank-
ing the mutation.
Conformation-Sensitive Gel Electrophoresis (CSGE)
Analysis
Screening for nucleotide changes in the other exons
of COL7A1 and in flanking intronic sequences was per-
formed by means of heteroduplex analysis as described
by Ganguly et al. (1993). After PCR amplification, the
products from the patient and a normal control subject
were mixed in a 2:1 ratio. The formation of heterodu-
plexes was enhanced by heating the products to 98C
for 5 min, followed by heating at 68C for 1 h. A 10-
ml sample was loaded onto a gel containing 10% poly-
acrylamide, 15% formamide, 10% ethylene glycol, and
0.5% glycerol-tolerant buffer (USB) and was subjected
to electrophoresis at 500 V for 16 h.
Keratinocyte Culture, RNA Extraction, and Reverse
Transcriptase–PCR (RT-PCR)
Keratinocytes were cultured from 5-mm punch bi-
opsies obtained from the patients, in the manner de-
scribed by Rheinwald and Green (1975) and Rochat et
al. (1994). Total RNA was extracted from confluent cell
layers by means of the guanidium thiocyanate method
described by Chomczynski and Sacchi (1987). cDNA
was generated from total RNA by reverse transcription
using random hexanucleotides (Pharmacia Biotech) and
Moloney murine leukemia–virus reverse transcriptase
(Stratagene). The following sets of exonic primers were
used to amplify and sequence cDNA: sense primer 5′-
GCCTGGAAGTGTGCCGAATG-3′ and antisense
primer 5′-CCCCCTTAGCACCCTTGAGT-3′, to am-
plify exons 71–76 (nucleotide positions 5805–6352 in
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the cDNA sequence [Genbank accession number
L02870]) (Christiano et al. 1994b), and sense primer 5′-
GGTCCACAGGGGTCTCCA-3′ and antisense primer
5′-CCAGGTCTCCAGCAAGGC-3′, to amplify exons
85–89 (nucleotide positions 6715–6967). The annealing
temperatures used were 60C and 55C, to amplify exons
72–75 and exons 85–89, respectively.
Sequencing
PCR products showing abnormal electrophoretic mo-
bility were gel purified and sequenced in the forward
and reverse orientations, by means of the ABI PRISM
AmpliTaq–reaction dye terminator cycle–sequencing kit
(PE Applied Biosystems) and an Applied Biosystems
model 373A automated sequencer.
Immunofluorescence (IF) Study
Indirect IF staining was performed on cryosections of
punch biopsies, with the monoclonal antibody LH7:2 to
the NC-1 domain of type VII collagen, diluted 1:1,000,
from Sigma Immuno Chemicals (Bruckner-Tuderman et
al. 1989). The FITC-labeled anti-mouse antibody (Sigma
Immuno Chemicals) was used as secondary antibody.
Antibodies to type IV collagen, laminin, and GB3
(BM600) and to bullous pemphigoid antiserum also
were used. For IF staining of keratinocytes in vitro, cells
were grown on glass coverslips and were incubated with
50 mg L-ascorbate/ml for 48 h prior to the antibody
incubations (Schumann et al. 1997). The IF staining was
performed with the monoclonal antibody LH-7.2 to the
NC-1 domain of human type VII collagen and with poly-
clonal antibodies to the collagenous and the NC-2 do-
mains (Bruckner-Tuderman et al. 1995). The FITC-la-
beled anti-mouse and anti-rabbit secondary antibodies
were obtained from Dako.
Protein Extraction and Immunoblot Analyses
For immunoblotting, age-matched control and DDEB
keratinocytes were cultured to subconfluency and then
were incubated with 50 mg L-ascorbate/ml for 48 h prior
to the extraction. The culture media and the cell layers
were extracted separately. The medium was precipitated
with ethanol in the presence of 10 mM EDTA and 1
mM Pefablock (Merck) as proteinase inhibitors (Ko¨nig
and Bruckner-Tuderman 1992), and the cell layer was
extracted with a neutral buffer containing 0.1 M NaCl,
10 mM EDTA, 20 mM Tris-HCl pH 7.4, 1% NP-40
(Sonnenberg et al. 1991). The samples were subjected
to SDS-PAGE on polyacrylamide gels with a 10%–15%
polyacrylamide gradient, to immunoblotting, and to a
semiquantitative immunoassay using domain-specific
collagen VII antibodies (Ko¨nig et al. 1992).
Pepsin Digestion
Fragmentation of type VII procollagen from control
and DDEB keratinocytes was performed by means of
limited pepsin digestion (Bruckner and Prockop 1981;
Burgeson 1993). For the enzyme reaction, cell extracts
were acidified by the addition of glacial acetic acid to a
final concentration of 0.1 M, and the samples were in-
cubated with 10 mg pepsin (Fluka)/ml at 5C for 2 h.
The reaction was stopped by neutralization with un-
buffered Tris. After ethanol precipitation at20C over-
night, the samples were dissolved in SDS-PAGE sample
buffer and were subjected to immunoblotting.
Electron Microscopy
Skin biopsies were taken, under local anesthesia, from
clinically uninvolved skin from the probands of families
1 and 2. Electron microscopy was performed on a por-
tion of a skin biopsy fixed in 2.5% glutaraldehyde and
processed by means of standard techniques as described
by Eady (1985). Sections were observed under a Jeol
1200 EX transmission-electron microscope.
Results
Identification of COL7A1 Deletions
To screen for mutations within COL7A1, the 118 ex-
ons and flanking intronic sequences were amplified from
genomic DNA. The PCR products were first tested on
2% agarose gels and were run on CSGE. Of the 118
exons analyzed, exon 73 and exon 87 showed abnormal
migration patterns on agarose-gel tests in patients 1 and
2, respectively, suggestive of the presence of a genomic
deletion in the corresponding fragments (fig. 2).
Patient 1.—PCR amplification of exon 73 showed a
smaller band in addition to the band of normal size, the
two bands being of comparable intensity (fig. 2a). Direct
sequencing of the smaller band revealed a 28-bp genomic
deletion in exon 73, spanning nucleotides 6081–6108
in exon 73 (6081del28) (fig. 3a). Sequence analysis of
the band of normal size showed a normal sequence.
DNA analysis of the proband’s affected daughter con-
firmed that she had inherited the 6081del28 mutation.
DNA from the patient’s parents was not available for
study.
Patient 2.—PCR amplification of exon 87 and flank-
ing intron sequences showed a band of reduced size in
addition to the band of normal size (fig. 2b). Direct
sequencing of the smaller band revealed a 27-nucleotide
deletion in exon 87, encompassing nucleotides 6847–
6873 (6847del27) (fig. 3b). Direct sequencing of the
band of normal size showed a normal sequence. The
presence of the 6847del27 mutation at a heterozygous
state was confirmed in the proband’s affected father.
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Figure 2 Genomic amplification of exons 73 and 87 from
COL7A1, and RT-PCR amplification of corresponding regions in pa-
tients 1 and 2. a, Family 1, in which amplification of exon 73 from
genomic DNA showed an extra band (258 bp) migrating faster than
the band of normal size (286 bp), in both patient 1 (lanes P1) and her
affected daughter (lane Da). Sequencing of this lower band showed a
28-bp deletion (6081del28) in exon 73, located 72 bp upstream of the
donor splice sites of intron 73. In patient 1, RT-PCR amplification of
the COL7A1 cDNA region from exons 71–76 showed a smaller band
(458 bp) than would be expected from the deletion. Sequence analysis
of this band confirmed 6081del28 and revealed abnormal splicing of
the last 62 nucleotides of exon 73. b, Family 2, in which genomic
amplification of exons 86 and 87 showed a smaller band (377 bp) in
addition to the band of normal size (404 bp) in both patient 2 (lanes
P2) and her affected father (lane Fa2). Sequencing of the lower band
showed a 27-bp deletion in exon 87, located 27 bp upstream of the
donor splice site of intron 87. In patient 2, RT-PCR amplification of
the COL7A1 cDNA region encompassing exons 85–89 showed a band
of reduced intensity and smaller size (184 bp) than would be predicted
from the deletion. Sequencing of this band (184 bp) revealed skipping
of exon 87. The reduction in intensity of this band may be due to
variable degradation of the mutated transcript, despite the fact that
the reading frame is maintained. Bands of abnormal size are denoted
by an asterisk (*). Numbering of the nucleotides refers to the cDNA
sequence published by Christiano et al. (1994b) (Genbank accession
number L02870).
Figure 3 Schematic representation of the genomic deletions of
exons 73 and 87 and associated abnormal splicing. Exons and parts
of exons present in the mRNA are shown as blank boxes, genomic
deletions of exons are shown as black boxes, and the exons or parts
of the exons that are removed by abnormal splicing are shown as
boxes with hatching. a, Patient 1. The 28-bp genomic deletion in exon
73 leads to abnormal splicing of the last 62 bp of this exon after the
activation of a cryptic GT donor splice site (underlined). The 10-bp
sequence (nucleotides 6109–6118) encoding the new amino acids
E2028, S2029, and L2030 between the 3′ end of the genomic deletion
and the cryptic GT donor splice is shown as in gray shaded. b, Patient
2. The 27-bp genomic deletion of exon 87 produces skipping of the
entire exon 87. These splicing abnormalities occurred despite the fact
that the consensus donor splice-site sequences of intron 73 and 87
remain intact.
Abnormal Splicing of Exons 73 and 87
Since the role of internal exon sequences in splice-site
selection recently has been documented in human dis-
ease, we sought to investigate splicing of exons 73 and
87 in patients 1 and 2, respectively.
Patient 1.—Amplification of exons 71–76 from re-
verse-transcribed total RNA from culture keratinocytes
showed a smaller band in addition to the band of normal
size, both bands being of comparable intensity (fig. 2a).
Direct sequencing of the smaller band showed the de-
letion of nucleotides 6081–6108 and the removal of the
last 62 nucleotides of exon 73 (nucleotides 6119–6180),
leaving nucleotides 6109–6118 unchanged (fig. 3a).
There was no evidence for normal splicing of exon 73
harboring the 6081del28 mutation. The abnormal splic-
ing of exon 73 should originate from the activation of
the cryptic splice donor site GT6119 within exon 73
(fig. 3a). The combination of the genomic deletion and
the splice abnormality restores the phase and predicts
the replacement of the last 11 Gly-X-Y repeats of exon
73 by noncollagenous sequence Glu-Ser-Leu (fig. 3a).
Sequencing of the band of normal size showed a normal
sequence.
Patient 2.—Amplification of exons 85–89 from re-
verse-transcribed RNA showed a smaller band in ad-
dition to the band of normal size (fig. 2b). Sequenc-
ing of the smaller band disclosed the removal of
Gly2278–Gln2300 encoded by exon 87, which was con-
sistent with skipping of this exon (fig. 3b). There was
no evidence for normal splicing of exon 87 harboring
the 6847del27 mutation.
Screening for the Mutations
The mutations that we report were not found in either
18 DDEB patients or 64 RDEB patients but were specific
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Figure 4 Indirect IF staining of control and patient’s keratino-
cytes, with antibodies to type VII collagen. Staining of normal human
keratinocytes (a and c) exhibits a weak granular intracellular IF,
whereas staining of keratinocytes of patients 1 (b) and (d) clearly show
increased immune reactivity, indicating intracellular accumulation of
type VII procollagen.
Figure 5 Immunoblotting of type VII collagen from control and
patient’s keratinocyte extracts. a,Intensity of 320-kD type VII pro-
collagen immunoblot band, which was stronger in keratinocyte ex-
tracts of patients 1 (lane Pat 1) and 2 (lane Pat 2) than in those of
controls (lanes Co). b, Semiquantitative immunoblot-based assay
(Ko¨nig and Bruckner-Tuderman 1992), demonstrating that the relative
intensity of type VII procollagen bands in the control, patient 1, and
patient 2 was 1:1.7:2.3, indicating that the DDEB keratinocytes ac-
cumulated type VII procollagen.
to the two families studied here. Neither mutation was
found in 50 normal controls. Complete screening of the
118 exons of COL7A1 and of their flanking splice sites
in patients 1 and 2 did not reveal additional nucleotide
variation predicting an amino acid change or a splicing
abnormality. Complete sequencing of introns 73, 86, and
87 showed a normal sequence.
IF of Skin Biopsies
IF labeling of skin biopsies with LH7:2 antibody
showed bright and linear staining along the dermo-ep-
idermal junction in both patients, similar to what was
seen in the control. Type IV collagen, laminin 5, and
bullous pemphigoid antigens were expressed normally.
Accumulation of Type VII Procollagen in Keratinocytes
in Vitro
IF staining with antibodies to type VII collagen dem-
onstrated a rather weak intracellular granular staining
in normal control keratinocytes (fig. 4a and c). In con-
trast, the DDEB keratinocytes of both patients revealed
a clearly increased intracellular type VII collagen con-
tent, as evidenced by a stronger IF signal (fig. 4b and
d). Use of different domain-specific antibodies estab-
lished that the material retained consisted of entire type
VII procollagen molecules, containing the NC-1, NC-2,
and triple-helical domains. Immunoblotting of keratin-
ocyte extracts confirmed the visual impression derived
from IF staining (fig. 5a). A single 320-kD band rep-
resenting the proa1(VII) polypeptide chain was found
in control and DEB cell media and extracts, but quan-
titative differences emerged. The type VII procollagen
bands derived from keratinocytes of patients 1 and 2
were stronger than those from controls. A semiquanti-
tative immunoblot assay using soluble chromophores
and spectrophotometric determination of the immuno-
blot signal revealed that the content of type VII pro-
collagen was higher in DDEB cells than in controls,
indicating intracellular accumulation of type VII pro-
collagen. When the signal intensity for controls was set
at 1.0, it was 1.7 in cells of patient 1 and was 2.3 in
cells of patient 2 (fig. 5b).
Pepsin Digestion of Mutant Type VII Procollagen
To allow investigation for the presence of the mutant
type VII procollagen molecules in the patient’s keratin-
ocytes, the cell extracts were subjected to a limited pepsin
digestion, a treatment that eliminates the globular
domains of collagens and that leaves the pepsin-resistant
triple-helical fragments undigested (Bruckner and
Prockop 1981). This proteolytic fragmentation was nec-
essary, since small deletions such as those in the present
probands cannot be discerned, by SDS-PAGE, in a poly-
peptide with a size 1300 kD (fig. 6, left panel). Since
type VII collagen is very sensitive to proteolysis, a low
enzyme concentration and a low reaction temperature
were chosen for the pepsin treatment. Under these con-
ditions, the globular NC-1 and NC-2 domains were re-
moved from type VII procollagen. In contrast, the triple-
helical domain mostly resisted digestion, except for a
partial cleavage, into P1 and P2 fragments, at the site
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Figure 6 Pepsin digestion of type VII procollagen, and immu-
noblotting with antibodies to the carboxy-terminus of type VII col-
lagen. Normal and DDEB keratinocyte extracts were digested with
pepsin, to produce smaller triple-helical type VII procollagen frag-
ments. In untreated extracts of the control and patient 1 and 2, the
320-kD type VII procollagen band was present (lanes Pepsin). A
limited digestion with pepsin (lanes Pepsin) resulted in the loss of
the intact procollagen and in appearance of the full-length triple helix
and its carboxy-terminal half, the P1 fragment (Burgeson 1993). The
amino-terminal half of the triple helix, the P2 fragment, was not rec-
ognized by the antibodies used here. In contrast to what was seen in
the control with a distinct P1 fragment, P1 derived from mutant type
VII procollagen of patient 1 appeared as a diffuse and broadened band,
and pepsin digestion of mutant type VII procollagen of patient 2 re-
sulted in a double P1 band, indicating that the mutant type VII collagen
molecules were hybrid trimers of normal length and shortened poly-
peptides. In the case of patient 1, pepsin treatment did not result in
complete digestion of the procollagen molecules but produced abnor-
mal high–molecular-weight cleavage products, suggesting that inclu-
sion of mutant polypeptides in the trimeric molecules had led to altered
proteinase sensitivity.
of the hinge region, located in the center of the triple-
helical domain, as has been described by Burgeson
(1993). In controls, the fragment pattern described
above was obtained (fig. 6, right panel). In case of patient
1, pepsin treatment yielded a diffuse band of the C-
terminal P1 fragment, and fragmentation of type VII
procollagen of patient 2 resulted in a distinct double
band of the P1 fragment (fig. 6, right panel). These bands
reflected the presence of normal and shorter, mutant
proa1(VII) polypeptides within the triple helices of type
VII procollagen in the patients. In addition, high-mo-
lecular-weight cleavage products were observed in pa-
tient 1, suggestive of altered proteinase sensitivity of the
mutated molecule (fig. 6, right panel).
The different pattern of the P1 fragment in patient 1
versus that in patient 2 likely reflects the location of the
deletion within the P1 fragment, with respect to the
hinge region. Patient 1’s deletion causes the replacement
of 11 Gly-X-Y triplets adjacent to the hinge region by
three amino acids, E-S-L, which disrupt a continuous
stretch of 24 glycine triplet repeats. The mutated se-
quence of the region C-terminal from the hinge region
now reads as follows: (G-X-Y)14-L-(G-X-Y)2 -E-S-L-
(G-X-Y)11-VSVDEPGP-(G-X-Y)38. This sequence con-
tains short Gly-X-Y repeats and multiple interruptions.
It therefore is predicted to be more sensitive to pepsin,
which would cleave this segment at several sites. As a
result, several P1 fragments of slightly different size ap-
pear as a diffuse band on SDS-PAGE in patient 1.
Also, the fact that variable amounts of high-molecu-
lar-weight cleavage products constantly were observed
with collagen VII from patient 1 supports the notion of
altered proteolytic sensitivity of the mutated region,
which presumably is due to altered protein folding at
this site. In contrast, the deletion in patient 2 is
located further C-terminally, at amino acid positions
2278–2300. This deletion resides in the middle of a long
uninterrupted triple-helical sequence. Therefore, pepsin
digestion of the hinge region in patient 2 produces a
distinct double band, representing both a normal and a
deleted P1 fragment.
The upper, normal P1 band from the patients appears
to migrate somewhat faster than that in the control (fig.
6, right panel). This was a constant observation with
the probands’ P1 fragment. The reasons for this faster-
migrating pattern remain unclear, but they may involve
alterations in posttranslational modifications. However,
very little is known about prolyl and lysyl hydroxylation
or glycosylation of nascent proa1(VII) chains in kera-
tinocytes. The normal P1 fragment contains 91 proline,
105 hydroxyproline, 9 lysine, and 41 hydroxylysine res-
idues/1,000 amino acids (Morris et al. 1986), and it is
conceivable that the trimeric molecules containing both
normal and mutated chains are not adequately modified
and that, therefore, they migrate faster.
AF Abnormalities
Electron microscopy of skin biopsies showed both
cleavage beneath the lamina densa and alterations of
AFs, in both patients. Patient 1 displayed a reduction in
the number of AFs, which were thin and hypoplastic
(fig. 7b). Patient 2 demonstrated rare AFs, which showed
a morphology rudimentary (fig. 7c) in comparison with
that in the control (fig. 7a).
Discussion
We have described two patients affected with DDEB
who are heterozygous for genomic deletions within ex-
ons 73 and 87 in the collagenous domain of COL7A1.
Both mutations alter splicing of the corresponding exon,
despite intact consensus splice-site sequences. In patient
1, the 6081del28 mutation is associated with activation
of a cryptic splice site within exon 73, and the combi-
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Figure 7 Electron microscopy of tissue of (a) the control, which shows AFs (arrows) of normal length and ultrastructure that insert into
the lamina densa, (b) skin from patient 1, which shows hypoplastic AFs reduced in number, and (c) patient 2, which shows tissue separation
(asterisk [*]) below the lamina densa and rare and poorly formed AFs. (Scale bar 0.5 mm; final magnification 26,400#)
Figure 8 Proposedmechanisms for genomic deletions6081del28
and 6847del27. a, Patient 1 (6081del28). Formation of a hairpin loop
by intrastrand pairing of inverted repeats 1-4 and 2-3 is shown. The
presence of stretches of G and C (underlined) located immediately
upstream of the loop would have favored slippage of the DNA poly-
merase and replication across the base of the loop, causing the loop
to be removed from the intervening sequence. Alternatively, excision
of the loop may have occurred during DNA replication. b, Patient 2
(6847del27). The presence of an 8-bp direct repeat (CCTGGCCC
[underlined]) may have favored accidental nucleotide pairing and de-
letion of the intervening 27-bp sequence during DNA replication.
nation of both defects results in the replacement of the
last 10 Gly-X-Y repeats from this exon by a non-
collagenous Glu-Ser-Leu sequence. In patient 2, the
6847del27 mutation causes in-frame skipping of exon
87 encoding 7 Gly-X-Y repeats and amino acid residues
Gly2299 and Gln2300. This first report of COL7A1
deletions in DDEB suggests different possible mecha-
nisms for abnormal splicing of exons 73 and 87 and
indicates that shortened type VII collagen polypeptides
can cause DDEB.
Proposed Mechanism Producing 6081del28 and
6847del27 Mutations
Analysis of the 6081del28 mutation identified in pa-
tient 1 shows that the 28-bp deleted sequence contains
two inverted repeats—CCGGC/GCCGG and GGC/
GCC—which could have potentiated the formation of
a single-stranded hairpin loop (fig. 8a). In addition, ex-
amination of the sequence in the vicinity of the deletion
shows two stretches—of 4 G residues and 6 C resi-
dues—immediately upstream of the deletion. Although
the role that these stretches of repetitive residues may
have in the generation of the deletion remains specula-
tive, it is possible that they may have favored slippage
of the DNA polymerase across the base of the loop dur-
ing DNA replication and have led to skipping of the 28-
bp sequence participating in the hairpin structure. Al-
ternatively, the deletion may have arise from excision of
the loop during DNA replication, as has been described
elsewhere for transposable elements (McConkey 1995).
In patient 2, analysis of the 6847del27 mutation
shows the presence of a CCTGGCCC repeated sequence
(underlined sequence in fig. 8b) located at the 5′ end of
the deleted sequence and immediately adjacent to its 3′
end. This sequence may have favored accidental nucle-
otide pairing, during DNA replication, and removal of
the intervening sequence, corresponding to the deletion
of nucleotides 6847–6873, through a slipped-strand–
mispairing mechanism (Krawczak and Cooper 1991).
A Role for Exons 73 and 87 Sequences In Splice-Site
Selection
In the absence of any other defect in the sequence of
exons and introns 73, 86, and 87, including their pu-
tative branch sites, we suggest that abnormal splicing of
exons 73 and 87 results from alteration in the sequence,
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size, and/or secondary structure of these exons, caused
by 6081del28 and 6847del27.
Since mutations in ESEs recently have been reported
in several disease genes reviewed by Cooper andMattox
(1997), we examined the possibility that such sequences
could be altered by the mutations that we have described
here. Analysis of the content, in purines and AC, of the
present deletions (42% for 6081del28 and 55% for
6847del27, the AC content being similar to the purine
content in each deletion) suggests that it is unlikely that
they are ESE or ACE sequences. However, there is cur-
rently no consensus sequence for ESE motifs, and we
cannot exclude the possibility that the partial deletions
of exon 73 and 87 alter previously unidentified regu-
latory regions involved in splice-site selection.
Other exonic mutations that affect splicing, despite
the presence of normal consensus splice sites, include
nonsense mutations, the mechanism of action of which
remains unclear (Dietz et al. 1993), and large deletions
or insertions changing the size and/or secondary struc-
ture of the exon (Eperon et al. 1988; Matsuo et al. 1992;
Narita et al. 1993). Skipping of exons containing non-
sense mutations has been reported in a number of disease
genes and is thought to involve a mechanism scanning
for maintenance of an open reading frame (Dietz and
Kendzior 1994). Abnormal splicing of exon 73 restores
the phase, suggesting that a similar mechanism possibly
could be involved. However, the 6081del28 mutation
does not create a PTC in exon 73 but does do so in
exon 82. Therefore, it remains uncertain whether
the open-reading-frame interruption caused by the
6081del28 mutation might contribute to abnormal splic-
ing of exon 73. In contrast, the 6847del27 mutation
maintains the reading frame, and thus it is not plausible
that skipping of exon 87 involves a termination-co-
don–recognition mechanism.
On the other hand, the reduction in size of exon 73
(from 201 to 173 bp) and of exon 87 (from 69 to 42
bp) alters the distance between the 3′ and 5′ splice junc-
tions of these exons. This distance has been shown, in
other genes, to be critical for “exon definition,” in the
sense that interacting splicing factors may require an
optimal interaction range across the exon (Reed 1996).
In particular, reduction of the size of exons to !50 bp
has been shown to lead to exon skipping (Dominski and
Kole 1991; Berget 1995). In addition, small exons (!60
bp) have been noted to have strong splice sites to prevent
them from being skipped (Zhang 1998). Therefore, we
calculated the scores for the splice-site sequences flank-
ing exon 87, as described by Shapiro and Senapathy
(1987). We found a score of .61 for positions 6 to 2
of the splice acceptor sequence of intron 86 and a score
of .63 for positions 2 to 6 of the splice donor se-
quence of intron 87. These relatively low values suggest
that shortening of exon 87 would have hindered rec-
ognition of this exon and its flanking splice sites during
spliceosome assembly and would have favored the use
of the stronger acceptor splice site of intron 87 (score
.84), leading to skipping of exon 87.
Finally, it is also possible that the removal of genomic
sequences disrupts the pre-mRNA secondary structure
of exons 73 and 87 that is important for splicing. In
support of this possibility, 6081del28 eliminates a hair-
pin from the predicted mRNA secondary structure of
exon 73 (obtained by use of the “Mfold” computer pro-
gram, for RNA, by Zuker (1994).
Mechanism for Abnormal AF Formation
The two deletions that we have described here result
in the synthesis of mutated type VII polypeptides that
would be 30 and 23 amino acid residues shorter than
the wild-type chains. In addition, a short noncollagenous
sequence is introduced into exon 73 in patient 1. By
analogy with other single-exon deletions in COL1A2,
COL3A1, and COL11A2 genes—reported in osteoge-
nesis imperfecta (OI) type I (Zhuang et al. 1993), Ehlers-
Danlos syndrome type IV (Kuivaniemi et al. 1995), and
dominant Stickler syndrome (Vikkula et al. 1995), re-
spectively—we suggest that these structurally abnormal
polypeptides associate with their normal partner and
impair folding of the triple helix in a dominant manner.
The alteration of protein conformation would account
for delayed secretion and intracellular accumulation of
type VII collagen molecules, as observed in culture ker-
atinocytes of the probands. In patient 1, the replacement
of the last 11 Gly-X-Y repeats of exon 73 by a Glu-Ser-
Leu sequence creates a segment of short Gly-X-Y repeats
and multiple interruptions adjacent to the hinge region.
In patient 2, skipping of exon 87 disrupts a continuous
stretch of 28 Gly-X-Y repeats in the 14th collagenous
subdomain. In both cases, shortening of the collagenous
domains creates a shift in the alignment of Gly-X-Y re-
peats in one chain relative to the other, in trimeric hybrid
molecules. In addition, although the center of the helix
accommodates only residues of glycine, the smallest
amino acid, in patient 1 the noncollagenous Glu-Ser-Leu
sequence introduces both a bulky and charged residue
(Glu) into the center of the triple helix, which may es-
tablish charge-charge interactions with neighboring
amino acid residues. We suggest that the reduction of
normal type VII collagen homotrimers and dominant-
negative effects of hybrid molecules containing mutated
chains would impair AF formation and cause loss of
dermal-epidermal adhesion in heterozygotes.
Because of both poor solubility and sensitivity to un-
specific degradation of procollagen VII in the medium
during biochemical manipulations (Burgeson et al. 1990;
Ko¨nig and Bruckner-Tuderman 1992), the ratio of nor-
mal and mutated molecules secreted by the patients’ cells
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could not be determined reliably. However, the paucity
and abnormal morphology of the AFs in the patients’
skin support the assumption that somemutantmolecules
are secreted and interfere with normal AF formation in
a dominant-negative manner. Similarly, studies of mu-
tated collagen I in OI have demonstrated that not only
normal but also some mutated collagen molecules are
secreted into the medium and contribute to the OI phe-
notype, via dominant-negative interference with fibril
formation (Raghunath et al. 1994).
Genotype-Phenotype Correlations
The COL7A1 defects that we have described here have
been identified in DDEB patients whose skin-blistering
condition had shown gradually improvement during
childhood and almost had ceased by the onset of adult-
hood. Interestingly, a COL7A1 splice-site mutation that
had been predicted to cause in-frame skipping of exon
36 recently has been described in dominantly inherited
transient bullous dermolysis of the newborn (Christiano
et al. 1997b). However, both the persistence, in the fam-
ilies that we have described, of blistering during late
childhood and the existence of AF abnormalities at
adulthood argue against the possibility that these pa-
tients could be affected with transient bullous dermolysis
of the newborn. Considerable intrafamilial phenotypic
variability was found in family 2, in which pretibial blis-
tering was noted in the proband only and did not occur
in his affected grandmother and father. The reasons for
these observations remain unclear, but they suggest that
other genetic determinants and/or environmental factors
could influence the phenotypic outcome of the muta-
tions. In this respect, it is possible that differences in the
expression of the mutated allele and/or in the degra-
dation of the abnormally folded protein could modulate
the severity of the disease (Ashkenas and Byers 1997).
Finally, one can speculate that in-frame removal of col-
lagenous sequences could underlie DEB phenotypes of
differing severity and modes of inheritance, as is the case
with glycine mutations in COL7A1 that cause DDEB or
RDEB.
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